Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients.
Saved in:
| Title: | Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. |
|---|---|
| Authors: | Nili M; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. mona.nili@boehringer-ingelheim.com., Epstein AJ; Medicus Economics, LLC, Milton, MA, USA., Nunag D; Medicus Economics, LLC, Milton, MA, USA., Olson A; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA., Borah B; Mayo Clinic, Rochester, MN, USA. |
| Source: | BMC pulmonary medicine [BMC Pulm Med] 2023 Jun 27; Vol. 23 (1), pp. 230. Date of Electronic Publication: 2023 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2466 |
|---|---|
| DOI: | 10.1186/s12890-023-02496-3 |
